Pfizer's COVID-19 vaccine trial data shows long-term efficacy in adolescents

23 Sept 04:58 Key points summarised by AI

Pfizer announced its COVID-19 vaccine demonstrated 100% efficacy in adolescents aged 12-15 years, maintaining strong protection for over four months after the second dose.
This robust long-term data will support planned submissions for full regulatory approval of the 30-microgram vaccine dose for individuals aged 12 and above, both in the U.S. and worldwide.

Uthenthawai students and alumni declare truce with Pathumwan rivals

Yesterday 20:34 Key points summarised by AI

Uthenthawai students and alumni have pledged to cease violent clashes with Pathumwan Institute rivals, coinciding with their campus's reopening after a 90-day closure.
The Minister of Higher Education is mediating the long-running conflict, while the campus closure has significantly disrupted in-person classes and laboratory work for over 1,000 students.
Uthenthawai resists relocation from its current site, citing a historical land grant from King Rama VI, despite Chulalongkorn University's plans to reclaim the land for an educational hub.
Concerns are mounting over the legality of the campus closure, its detrimental impact on uninvolved students, and the potential commercial development of the land, which critics argue contradicts the late King Rama VI's intentions.